Bernstein on Intuitive Surgical (ISRG): 'Upside to Q3 on Placements & Procedures'

Bernstein SocGen Group analyst Lee Hambright reiterated an Outperform rating and $685.00 price target on Intuitive Surgical (NASDAQ: ISRG).

The analyst commented: "Upside to Q3 on placements & procedures; Bottom line: Consensus numbers for 2026 ($9.18 EPS) appear quite conservative. Bigger picture, robotic-assisted surgery is very large, underpenetrated global market. Intuitive has a 20-year lead and a formidable competitive moat. As da Vinci 5 begins broad launch, the company is just about to hit its stride on Ion, SP and refurbished Xi product cycles as well, and we continue to see a steady cadence of meaningful software innovation from ISRG (e.g., Force Gauge, in-console video replay, AI-enabled 7th-gen Ion software)."

For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.

Shares of Intuitive Surgical closed at $458.47 yesterday.

You May Also Be Interested In

• GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
• Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen
• Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'